ghk-cu silences free copper redox activity Research Peptide CJC-1295 No DAC Vial YGroup_adenosyl-hydroxy-b12-90 Dose:5 mg

ghk-cu silences free copper redox activity Research Peptide CJC-1295 No DAC Vial YGroup_adenosyl-hydroxy-b12-90 Dose:5 mg

CJC-1295 No DAC Vial — Lyophilized, HPLC + COA | Omnix

If you experience severe nausea or vomiting, chest pain, palpitations, signs of an allergic reaction, or persistent abdominal pain, contact your GP or call NHS 111 promptly

YGroup_adenosyl-hydroxy-b12-90

Dose:5 mg

The compound was developed by Metabolic Pharmaceuticals (now Calzada Ltd.) specifically to replicate the fat-metabolizing effect of GH without the receptor-binding regions responsible for IGF-1 induction, linear growth, or insulin antagonism